Various factors have been suggested to contribute to this association, including altered insulin signaling, hyperglycemia, advanced glycation, chronic low-grade inflammation, small vessel disease (SVD), large vessel disease, and Alzheimer’s disease (AD) pathology2, but specific pathways and their relationship with AD biomarkers are complex and not fully understood. The gene discussed is INS; the disease is Alzheimer disease.